STOCKS TELEGRAPH

Tag: BIOLASE

  • BIOLASE, Inc. (BIOL) Witnesses Remarkable Surge with Earnings Beat

    BIOLASE, Inc. (NASDAQ: BIOL) saw a relatively subdued trading day on Thursday, with its shares ticking up by a marginal 0.60% from $0.1491 to $0.1500. However, the after-market scenario presented a starkly different narrative. Following the unveiling of its earnings report, BIOLASE experienced an astounding surge of 47%, propelling its stock price north of the $0.22 threshold.

    Exceeding Projections in Earnings

    Contrary to analysts’ predictions pegging the EPS figure at -$2.56 for Q4, BIOLASE surpassed expectations by revealing a substantially reduced loss of -$1.76. Moreover, the company’s revenue for the period closely mirrored the provided guidance, showcasing commendable performance amidst a challenging market milieu.

    Positive Performance Metrics

    Amidst the turbulence of 2023, BIOL showcased resilience and growth momentum across pivotal performance indicators. Noteworthy achievements encompassed record-breaking consumable sales, a significant uptick in the adoption of its laser systems, and an impressive 45% surge in the sales conversion rate, attributed to the triumphant Waterlase Trial Program.

    John Beaver, BIOL’s President and CEO, underscored the company’s proactive endeavors in heightening awareness and interest in its dental lasers, foreseeing continued growth momentum into 2024.

    Financial Highlights

    Biolase disclosed a net revenue of $49.2 million for the fiscal year concluding on December 31, 2023, exceeding its own market capitalization by over 5 times. Particularly noteworthy was the robust 31% year-over-year growth in U.S. consumables and other revenue streams.

    Despite prevailing challenges, BIOLASE managed to enhance its gross margin and significantly curtail operating expenses, resulting in a diminished operating loss vis-à-vis the prior fiscal year.

    Strategic Outlook

    Bolstered by approximately $6.6 million in cash and cash equivalents as of December 31, 2023, supplemented by an additional $7.0 million in gross proceeds raised in February 2024, BIOLASE stands primed to execute its growth strategies. The company’s strategic focus on amplifying growth while streamlining operations underscores its unwavering commitment to delivering sustained value to its shareholders.

    Concluding Remarks

    As BIOLASE continues to surpass expectations and navigate through the choppy waters of uncertain market dynamics, investor sentiment remains increasingly sanguine about its future trajectory. With revenue outpacing total market capitalization by a substantial margin, BIOLASE’s upward trajectory augurs well for sustained growth and value creation in the foreseeable future.

  • Looking for $1 Stock? BIOLASE (BIOL) is a Decent Bet

    Looking for $1 Stock? BIOLASE (BIOL) is a Decent Bet

    The dental device firm is bullish and looks solid for long-term growth.

    The medical device firm, BIOLASE Inc. (BIOL) had a good last twelve months–soaring more than 20% up-to-date. Analysts are bullish on the dental firm stock and expect the stock to grow up to 255% in the next 12-months.

    BIOLASE along with its subsidiaries manufactures and markets dental laser systems for practitioners and patients across the U.S. and worldwide. The company covers different areas of dental diagnostics including cosmetic, complex surgical applications, and restorative.

    Most of the analysts rate the stock as a strong buy—and the average trading volume of 23.8 million backs it as well. Is investing in a $1 stock a good option?

    What’s happening?

    BIOLASE has developed its ecosystem in medical device development manufacturing. It is popular for its dental lasers across the globe—a leader in this category. In recent times, the company has made notable progress that would ensure the growth of BIOLASE going forward.

    About a week ago, the company signed an agreement with Dental Care Alliance (DCA) in the U.S. with almost 330 affiliated practices in 20 states. The DCA is one of the largest dental support organizations (DSO) across the country. Through this alliance, BIOLASE will expand laser adoption and hands-on training programs in specific areas. This will help the company to enhance its ecosystem while attracting real-time users of its laser devices during the program. Also, this agreement will open ways for the medical device maker to roll out across all DCA offices in 2021.

    The company has two standard lasers which include EpicX™ and Epic Hygiene™ for the dental industry. The company focuses on a new standard of technology providing good quality services and hygiene appointments—important during the COVID-19 pandemic.

    The CEO and President of BIOLASE, Todd Norbe said that the demand for EpicX and Epic Hygiene lasers is increasing. In the first three weeks of January, the company has already sold more than 100 systems to DCA. The collaboration with DCA will continue to consume more Epic lasers in the coming months across different areas in the country. 

    In late 2020, the company announced its partnership with BMW Performance Center West The Therman Club near Palm Springs (BMW PCW). This deal will allow dentists to take part in Waterlase Weekends—two group trips including a 4-hour event at the BMW PCW. This is kind of a promotion deal for BIOLASE—helping the company to expand its ecosystem.

    Conclusion

    BIOLASE’s growth over the last year has been significant and the demand for its dental laser products is also increasing. The partnership deals to promote its devices will allow the company to attract more consumers—creating a bigger userbase. The growth of the company will help the stock to grow in the long-term. BIOLASE (BIOL) stock has already kicked off 2021 will a strong push. With the recent collaborations, the potential growth opportunity is there for the company. All the stats and business deals show the BIOL is a decent stock to bet on—a stock at around $1 per share.

  • 49 Stocks Making Sharp Moves in Pre Market Session

    49 Stocks Making Sharp Moves in Pre Market Session

    BlackBerry Limited (BB) stock soared 21.29% to $8.49 in the pre-market trading following the announcement of its multi-year, global agreement with Amazon Web Services, Inc. (AWS). The most recent rating by TD Securities, on April 01, 2020, is a Hold.
    Gores Metropoulos Inc. (GMHI), a Shell Companies company, dropped about -3.71% at $16.37 in pre-market trading Wednesday.
    Carnival Corporation & Plc (NYSE: CCL) shares are trading up 2.48% at $20.65 at the time of writing. The firm recently reported Peter C. Anderson as a Section 16 Named Executive Officer. Company’s 52-week ranged between $7.80 to $51.94. Analysts have a consensus price target of $31.
    Guardion Health Sciences Inc. (GHSI) is up more than 2.11% at $0.3 in pre-market hours Wednesday December 02, 2020. The stock had jumped over 11.71% to $0.29 in the last trading session.
    Advaxis Inc. (ADXS) grew over 0.85% at $0.32 in pre-market trading today. The healthcare company recently announced closing of $9.2 million public offering.
    Before the trading started on December 02, 2020, RiceBran Technologies (RIBT) is down -5.56% to reach $0.68. It has been trading in a 52-week range of $0.37 to $2.43.
    Sundial Growers Inc. (SNDL) stock moved up 5.75 percent to $0.69 in the pre-market trading and the company recently announced elimination of senior secured second lien convertible notes.
    Kaixin Auto Holdings (KXIN) is up more than 4.55% at $7.35 in pre-market hours Wednesday December 02, 2020. The stock had jumped over 8.32% to $7.03 in the last trading session.
    Moleculin Biotech Inc. (MBRX) lost over -7.83% at $0.9125 in pre-market trading Wednesday December 02, 2020 after declaring that the US Food and Drug Administration (FDA) has approved its request for a “Rare Pediatric Disease” designation for its drug candidate WP1066.
    Jaguar Health Inc. (JAGX) stock plunged -5.83% to $0.4313 in the pre-market trading. The most recent rating by Rodman & Renshaw, on July 11, 2017, is a Buy.
    Auris Medical Holding Ltd. (EARS) stock plunged -17.97% to $4.29 in the pre-market trading after reporting positive efficacy data from testing AM-301 in vitro. The most recent rating by Euro Pacific Capital, on October 08, 2018, is a Buy.
    Before the trading started on December 02, 2020, Sunworks Inc. (SUNW) is up 9.88% to reach $4.67. It has been trading in a 52-week range of $0.29 to $8.50.
    China Automotive Systems Inc. (NASDAQ: CAAS) shares are trading down -4.95% at $8.25 at the time of writing after the firm declared that its shipped approximately 120,000 units from its portfolio of electric power steering products for use in Chinese electric vehicles during 2020. Company’s 52-week ranged between $1.42 to $10.50.
    Tilray Inc. (NASDAQ: TLRY) shares are trading up 1.61% at $8.2 at the time of writing. Company’s 52-week ranged between $2.43 to $22.95. Analysts have a consensus price target of $4.77.
    Ocugen Inc. (OCGN) lost over -8.87% at $0.3101 in pre-market trading Wednesday December 02, 2020. The company recently reported that leading independent proxy firms ISS and Glass Lewis recommended Ocugen stockholders vote “FOR” reverse stock split and authorized shares amendment proposals.
    AMC Entertainment Holdings Inc. (AMC) is up more than 2.41% at $4.25 in pre-market hours Wednesday December 02, 2020. The stock had dropped over -2.81% to $4.15 in the last trading session.
    Before the trading started on December 02, 2020, JetBlue Airways Corporation (JBLU) is down -4.67% to reach $14.7 following the declaration of its pricing of common stock offering. It has been trading in a 52-week range of $6.61 to $21.65.
    Before the trading started on December 02, 2020, Uxin Limited (UXIN) is down -3.65% to reach $1.32. It has been trading in a 52-week range of $0.72 to $3.10.
    Li Auto Inc. (NASDAQ: LI) shares are trading up 1.78% at $35.48 at the time of writing after announcing that the Company delivered 4,646 Li ONEs in November 2020. Company’s 52-week ranged between $14.31 to $47.70. Analysts have a consensus price target of $45.60.
    Aurora Cannabis Inc. (ACB) stock soared 3.59% to $10.1 in the pre-market trading. The most recent rating by Jefferies, on November 16, 2020, is an Underperform.
    Tantech Holdings Ltd (TANH), a Household & Personal Products company, dropped about -3.24% at $1.79 in pre-market trading Wednesday after reporting the launch by its subsidiary, Shangchi Automobile Co., Ltd., of its newest highly innovative driverless and autonomous street sweeper.
    Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) shares are trading down -5.52% at $1.37 at the time of writing. Company’s 52-week ranged between $0.91 to $9.78. Analysts have a consensus price target of $3.
    iBio Inc. (IBIO) is up more than 19.31% at $1.73 in pre-market hours Wednesday December 02, 2020 after revealing that it has entered into its first Statement of Work (“SoW”) under a Master Services Agreement with ATB Therapeutics to produce its bioengineered antibody-toxin fusion proteins using iBio’s FastPharming® System. The stock had dropped over -2.68% to $1.45 in the last trading session.
    Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) shares are trading up 2.09% at $23.42 at the time of writing. Company’s 52-week ranged between $7.03 to $59.78. Analysts have a consensus price target of $26.
    Moderna Inc. (MRNA) stock soared 6.09% to $149.6 in the pre-market trading. The biotechnology firm reported recently, that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The most recent rating by Wells Fargo, on November 23, 2020, is an Equal weight.
    Switchback Energy Acquisition Corporation (SBE) is down more than -4.16% at $28.13 in pre-market hours Wednesday December 02, 2020. The stock had dropped over -12.67% to $29.35 in the last trading session.
    Novavax Inc. (NVAX) grew over 4.84% at $129.44 in pre-market trading today after declaring COVID-19 vaccine clinical development progress.
    Before the trading started on December 02, 2020, Eastman Kodak Company (KODK) is up 3.88% to reach $7.5. It has been trading in a 52-week range of $1.50 to $60.00.
    ReneSola Ltd (SOL), a Solar company, dropped about -11.66% at $6.97 in pre-market trading Wednesday after releasing its third quarter 2020 financial results.
    Acasti Pharma Inc. (ACST) stock plunged -9.56% to $0.3301 in the pre-market trading. The most recent rating by Oppenheimer, on September 01, 2020, is a Perform.
    Pfizer Inc. (PFE) stock moved up 3.73 percent to $40.88 in the pre-market trading after the firm and BioNTech SE reporting that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine (BNT162b2), against COVID-19.
    Gevo Inc. (NASDAQ: GEVO) shares are trading down -3.17% at $1.83 at the time of writing. Company’s 52-week ranged between $0.46 to $2.91.
    Fisker Inc. (FSR) is down more than -3.41% at $17.55 in pre-market hours Wednesday December 02, 2020. The company recently reported that that Henrik Fisker, chairman and chief executive officer of Fisker, will participate in the Credit Suisse Eighth Annual Virtual Industrials Conference. The stock had dropped over -6.24% to $18.17 in the last trading session.
    Nxt-ID Inc. (NXTD) grew over 43.17% at $0.587 in pre-market trading today.
    Before the trading started on December 02, 2020, Bloom Energy Corporation (BE) is down -6.58% to reach $23.0 and the company will host virtual analyst day on December 16, 2020. It has been trading in a 52-week range of $3.00 to $28.24.
    Ocean Power Technologies Inc. (OPTT), a Electrical Equipment & Parts company, dropped about -3.54% at $2.45 in pre-market trading Wednesday.
    Nikola Corporation (NKLA) stock soared 4.38% to $18.13 in the pre-market trading after signing MOU with General Motors. The most recent rating by Loop Capital, on November 20, 2020, is a Buy.
    Vaxart Inc. (VXRT) gained over 3.92% at $7.95 in pre-market trading Wednesday December 02, 2020.
    salesforce.com inc. (CRM) lost over -4.16% at $231.3 in pre-market trading Wednesday December 02, 2020 after introducing service cloud workforce engagement to help contact centers thrive in an all-digital, work-from-anywhere world.
    InVivo Therapeutics Holdings Corp. (NVIV), a Biotechnology company, rose about 2.42% at $0.635 in pre-market trading Wednesday.
    FuelCell Energy Inc. (FCEL) stock plunged -20.11% to $7.23 in the pre-market trading following the publication pricing of its underwritten public offering of 34,518,539 shares of its common stock, at a public offering price of $6.50 per share. The most recent rating by JP Morgan, on November 19, 2020, is a Neutral.
    Pershing Square Tontine Holdings Ltd. (PSTH), a Shell Companies company, rose about 2.34% at $26.25 in pre-market trading Wednesday.
    Virgin Galactic Holdings Inc. (NYSE: SPCE) shares are trading up 4.37% at $29.59 at the time of writing after reporting its new flight window since it paused the spaceflight preparations in response to state guidelines from the New Mexico Department of Health to reduce the spread of COVID-19. Company’s 52-week ranged between $7.14 to $42.49. Analysts have a consensus price target of $19.
    Second Sight Medical Products Inc. (EYES) stock moved down -8.0 percent to $1.38 in the pre-market trading.
    BioNTech SE (BNTX) grew over 7.36% at $122.4 in pre-market trading today after declaring that it will hold a press conference including a video webcast on Wednesday, December 2, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine candidate BNT162b2.
    Sogou Inc. (SOGO), a Internet Content & Information company, rose about 3.09% at $8.68 in pre-market trading Wednesday.
    Tellurian Inc. (TELL) is down more than -4.29% at $1.56 in pre-market hours Wednesday December 02, 2020 and the firm recently declared the appointment veteran CEO and adds industry experts to board of directors. The stock had jumped over 9.40% to $1.63 in the last trading session.
    Arlo Technologies Inc. (ARLO) lost over -3.48% at $6.66 in pre-market trading Wednesday December 02, 2020.
    Before the trading started on December 02, 2020, ZoomInfo Technologies Inc. (ZI) is down -3.57% to reach $46.22 as the firm announced pricing of secondary offering of shares of class a common stock. It has been trading in a 52-week range of $30.83 to $64.40.